Clinically Relevant Resistance in Cancer Chemotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology
Cover of the book Clinically Relevant Resistance in Cancer Chemotherapy by , Springer US
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461511731
Publisher: Springer US Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461511731
Publisher: Springer US
Publication: December 6, 2012
Imprint: Springer
Language: English

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long­ term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long­ term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

More books from Springer US

Cover of the book New Techniques in the Analysis of Foods by
Cover of the book School Consultation by
Cover of the book Evaporative Air Conditioning Handbook by
Cover of the book Frozen Section Library: Bone by
Cover of the book Biology of Brain Dysfunction by
Cover of the book Snapshots of Hemodynamics by
Cover of the book Principles of CAD by
Cover of the book Alternative Approaches to Human Blood Resources in Clinical Practice by
Cover of the book Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment by
Cover of the book Sensory Integration by
Cover of the book Police as Problem Solvers by
Cover of the book Institutional Analysis and Economic Policy by
Cover of the book The Causal Structure of Long-Term Supply Relationships by
Cover of the book A Practical Guide to Acceptance and Commitment Therapy by
Cover of the book Current Issues in Clinical Psychology by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy